Abstract
Rheumatoid arthritis (RA) is mainly an auto-immune disease characterized by inflammation in joints. 1 in 50 people develop RA at some stage and at any age. This review summarizes the etiology, pathophysiology, risk factor, and treatment related to RA. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on RA.
Keywords: Arthritis, RA, DMARDs, Diagnosis, Pathophysiology, NSAIDs, TNF modifiers, Nutraceuticals
Mini-Reviews in Medicinal Chemistry
Title: Rheumatoid Arthritis: A New Challenge in Coming Era
Volume: 10 Issue: 2
Author(s): Prarthana V. Rewatkar, Ganesh R. Kokil, Arunima Verma and Suresh Thareja
Affiliation:
Keywords: Arthritis, RA, DMARDs, Diagnosis, Pathophysiology, NSAIDs, TNF modifiers, Nutraceuticals
Abstract: Rheumatoid arthritis (RA) is mainly an auto-immune disease characterized by inflammation in joints. 1 in 50 people develop RA at some stage and at any age. This review summarizes the etiology, pathophysiology, risk factor, and treatment related to RA. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on RA.
Export Options
About this article
Cite this article as:
V. Rewatkar Prarthana, R. Kokil Ganesh, Verma Arunima and Thareja Suresh, Rheumatoid Arthritis: A New Challenge in Coming Era, Mini-Reviews in Medicinal Chemistry 2010; 10 (2) . https://dx.doi.org/10.2174/138955710791185136
DOI https://dx.doi.org/10.2174/138955710791185136 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting CD147 is a Novel Strategy for Antitumor Therapy
Current Pharmaceutical Design The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking
Recent Patents on Anti-Cancer Drug Discovery The Evolving Therapy of Rheumatic Diseases, The Future is Now
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Gold and Silver Nanoparticles for Applications in Theranostics
Current Topics in Medicinal Chemistry Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?
Current Medicinal Chemistry Pre-B Cell Colony Enhancing Factor/NAMPT/Visfatin in Inflammation and Obesity- Related Disorders
Current Pharmaceutical Design Wealth of Opportunity - The C1 Domain as a Target for Drug Development
Current Drug Targets A Realistic Approach for Anti-Inflammatory, Antinociceptive and Antimutagenic Activities, and Risk Assessment of the Aqueous Extract of <i>Platanus orientalis</i> L. Leaves
Current Molecular Pharmacology Editorial [Hot Topic: Genome and Proteome Analyses of Autoimmune Diseases (Executive Editor: G. Neeck)]
Current Pharmaceutical Design Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design Preface
Current Drug Targets - Inflammation & Allergy Biomedical Consequences of Alcohol Use Disorders in the HIV-Infected Host
Current HIV Research Glucocorticoids and the Cardiovascular System: State of the Art
Current Pharmaceutical Design Subject Index To Volume 2
Current Rheumatology Reviews Nanomedicine for Intra-Articular Drug Delivery in Rheumatoid Arthritis
Current Medicinal Chemistry A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases
Current Pharmaceutical Design Application of Nano- and Micro-Particles on the Topical Therapy of Skin-Related Immune Disorders
Current Pharmaceutical Design Mouse Models of Primary Biliary Cirrhosis
Current Pharmaceutical Design Toll-Like Receptors: Sensor Molecules for Detecting Damage to the Nervous System
Current Protein & Peptide Science Novel Approaches for Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents